Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 11 - Jul 16
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Current Insights, Advantages and Challenges of Small Molecule Glucagon like Peptide 1 Receptor Agonists: A Scoping Review Published in Journal of Brown Hospital Medicine croaie smgt glp 1 Croaie GLP 1 20 in 1 Slim& Healthy Oral Solution Une avance dans la prise en charge de l'obsit, source de nombreuses pathologies cardiaques dont l'insuffisance cardiaque partir du 15 juin, les agonistes GLP 1 seront rembourss pour les patients prsentant Many people remain excluded from GLP 1 clinical trials for weight loss Noom: Lose weight and keep it off. Battle of the diabetes drugs: GLP 1 RAs vs metformin for dementia Scimex
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 1849 reviews
Sort
Product Reviews
★★★★★ 5
Must Have Book for Investors or Sponsors/GPs wanting to Invest in Multifamily Properties!
Format: Paperback
If you understand the math and numbers associated with investing in real estate, this book will help you underwrite any multifamily property. Not only does Robert's book discuss how to gather the information needed for underwriting, he goes into detail on how sponsors can manipulate the numbers. This is a great book for knowledge on the pros and cons of varied partnership structures and how each can create an alignment of interest between limited partners (LPs) and general partners (GPs). Overall, this is a great easy read book.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 13, 2020
★★★★★ 4
Basic knowledge of underwriting is necessary to understand.
Format: Paperback
This is a great guide for underwriting multifamily deals for someone with some basic to moderate knowledge of underwriting. I am a new student to this field and have to stop and google some of the acronyms. For a future version, I think adding an extra page for the acronyms used, definition and equation would be helpful. I think that the font could be larger and darker. Adding mathematical formulas in the book would provide visualization as well. Rob can also provide a sample OM for the reader to use with his underwriting model and compare to his completed one. Again, I am a newbie so my review may change as I gain knowledge in this area. I enjoyed listening to Rob on Youtube/Podcast and hope to learn more from him.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 27, 2020
★★★★★ 5
Easy to understand and well organized
Format: Paperback
Author makes complex concepts feel approachable and easy to comprehend. The content is sufficient to be an introductory course
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 22, 2025
★★★★★ 5
great read for underwriters of multifamily deals
Format: Kindle
Rob lays out a succinct and thorough summary of his underwriting process, questions industry standards while sharing his opinions, and discusses risk management and analyses for deals during the underwriting process. Highly recommend for newer and more seasoned underwriters and investors to build or sharpen multifamily underwriting fundamentals and details. He also shares his model as the example.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 27, 2023
★★★★★ 3
Needs more meat
Format: Paperback
A little on the light side of information provided. Some nuggets. OK value.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 16, 2022
recommand products
VAResearchNewsBrief: Orlando VA Healthcare System researchers and academic partners showed injectable glucose-lowering medications called GLP1-RAs led to less hospital use and lower mortality than other medications in patients with type 2 diabetes
23.58
Natural Ozempic Alternatives: Can You Balance Blood Sugar and Lose Weight Without Medication?
28.07
OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs
24.28
Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs
24.44
TRICARE Coverage of Weight Loss Medications: What To Know > TRICARE Newsroom > TRICARE News
29.32